|
View previous topic :: View next topic |
Author |
Message |
agate Site Admin
Joined: 17 May 2006 Posts: 5694 Location: Oregon
|
Posted: Fri Nov 03, 2006 3:15 pm Post subject: (Abstract) Treatment of neuropsychiatric conditions in MS |
|
|
From PubMed, 11/3/06:
Quote: |
Expert Rev Neurother. 2006 Oct;6(10):1555-67
Treatment of neuropsychiatric conditions associated with multiple sclerosis
Ameis SH, Feinstein A.
University of Toronto, Sunnybrook Health Sciences Center, 2075 Bayview, Avenue, Toronto, Ontario, M4N 3M5, Canada. stephameis@hotmail.com
This article reviews the treatment of behavioral disturbances associated with multiple sclerosis. Pharmacological and psychotherapeutic treatment data, when available, are presented for five discrete conditions: major depression, bipolar affective disorder, anxiety, psychosis, pseudobulbar affect and cognitive dysfunction.
Despite the paucity of empirical treatment data that characterizes all of these conditions, with the exception of pseudobulbar affect, the message from open-label trials and anecdotal experience is that therapy is often successful, leading to improvements in quality of life for patients. Thus, all health professionals involved in the care of multiple sclerosis patients should have a good working knowledge of the neurotherapeutics of multiple sclerosis-related behavioral disorders.
|
|
|
Back to top |
|
|
ewizabeth
Joined: 29 May 2006 Posts: 549 Location: Near Chicago
|
Posted: Fri Nov 03, 2006 4:53 pm Post subject: |
|
|
Agate,
I had the pseudobulbar affect several years before I was diagnosed. Now, that is an embarassing symptom. _________________ Ewizabeth
DX 01/28/03 RRMS
Formerly Avonex, Rebif & Copaxone
Tysabri 06/07 through 09/09
On Copaxone again since 12/09 and hoping for oral meds to come out! |
|
Back to top |
|
|
|
|
You can post new topics in this forum You can reply to topics in this forum You can edit your posts in this forum You can delete your posts in this forum You cannot vote in polls in this forum
|
|
|